Last updated: April 24, 2026

Application No. 19/396,502

Untitled Application

Unknown

Filed

1600

Examiner

LAU, JONATHAN S

Art Unit

1693

Tech Center

Takeda Pharmaceutical Company Limited

Assignee

Takeda Pharmaceutical Company Limited

OA Round

1 (Non-Final)

Interview Optional

— -18.8% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1029 resolved cases, 2023–2026

Examiner Intelligence

LAU, JONATHAN S View full profile →

Grants 64% of resolved cases

Career Allow Rate

655 granted / 1029 resolved

+3.7% vs TC avg

Minimal -19% lift

Without

With

+-18.8%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

42 currently pending

Career history

1071

Total Applications

across all art units

Statute-Specific Performance

§101

1.9%

-38.1% vs TC avg

§103

40.1%

+0.1% vs TC avg

§102

17.9%

-22.1% vs TC avg

§112

22.4%

-17.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1029 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 12, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/798,099

Patent 12606590

MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE

2y 5m to grant Granted Apr 21, 2026

17/843,818

Patent 12600740

FLUORINATED N-ACETYL GLUCOSAMINE ANALOGS AND XYLOSE DERIVATIVES

2y 5m to grant Granted Apr 14, 2026

18/332,157

Patent 12590117

HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF

2y 5m to grant Granted Mar 31, 2026

18/016,172

Patent 12583879

METHOD FOR SYNTHESIZING C-NUCLEOSIDE COMPOUND

2y 5m to grant Granted Mar 24, 2026

18/512,798

Patent 12583945

SYNTHESIS OF UNIFORMLY DEFINED MOLECULAR WEIGHT MANNOSYLATED DEXTRANS AND DERIVATIVES THEREOF

2y 5m to grant Granted Mar 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

64%

Grant Probability

45%

With Interview (-18.8%)

3y 0m

Median Time to Grant

Low

PTA Risk

Based on 1029 resolved cases by this examiner. Grant probability derived from career allow rate.